AT THE FOREFRONT OF

CRISPR THERAPEUTICS DEVELOPMENT

A NOVEL CRISPR TECHNOLOGY

Directly addressing the inherent limitations of current CRISPR methodologies, we seek to unlock previously unattainable avenues in the development of CRISPR based therapeutics.

TECHNOLOGICAL FEATURES

Unprecedented

Corrective

Repair Rates

Safety from

off-target

and

Immunogenicity

Unique

RNP Delivery

Highly Efficient

Cellular Delivery

"WHAT WILL REPLACE Cas9 IS A HIGH FREQUENCY PRECISION EDITING HDR METHODOLOGY"

FIND OUT MORE.

CONTACT US.

AddressesInes

Institut NEOMED

7171 Frederick Banting
Saint-Laurent H4S 1Z9

(Québec) Canada

123 Edward Street, Suite 255

Toronto, M5G 1E2

Canada

Email

laurent.ziri@jenthera.com